Rohini Chaudhari

  • Surgical Face Masks Market to Perceive Substantial Growth by the End 2030

    Surgical Face Masks Market: Introduction

    • Surgical mask is a disposable, loose fitting device, which creates physical barrier between nose and mouth of the wearer and potential contaminants in the immediate environment. Surgical masks are available with different thickness and ability to protect from contaminants.

    Report Overview @

    https://www.transparencymarketresearch.com/surgical-face-mask-market.html

    • These masks are typically used to protect the wearer from large-particle droplets, splashes, and sprays. Additionally, these prevents the spread of infectious respiratory secretions from wearer to others.

    Planning To Lay Down Future Strategy? Request Brochure Of Surgical Face Masks Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42122

    Key Drivers and Opportunities of Global Surgical Face Masks Market

    • The world is currently experiencing the pandemic of an infectious disease called COVID-19. This infection leads to multiple organ failure, acute & severe respiratory disorders, pneumonia, and even death in severe cases. Hence, surge in number of people with coronavirus infections is anticipated to drive the global surgical face masks market. According to the World Health Organization, globally, 823,626 confirmed and 72,736 new cases of COVID-19 were recorded as of April 1, 2020. Additionally, in the context of the novel coronavirus (2019-nCoV) outbreak, the World Health Organization recommends the use of masks in home and health care settings. This in turn increases demand for surgical marks. Hence, rise in demand for surgical masks is likely boost the growth of the global market.
    • The use of face mask is vital to control infectious diseases, especially in circumventing droplet transmission. The effectiveness of surgical face mask in blocking the transmission of SARS is 68%. Therefore, it is widely used by medical workers as part of droplet transmission precaution when caring for patients with respiratory infections. Hence, increase in use of surgical face masks is projected to fuel the growth of the global surgical face masks market. Furthermore, vulnerable populations, such as older adults with chronic conditions, are at high risk of infectious diseases, including COVID-19. Hence, the use of face mask to prevent infections by the geriatric population is anticipated to drive the global market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Surgical Face Masks Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=42122

    • Moreover, face masks provide effective protection against respiratory infections. Rise in focus on production of protective equipment including face masks owing to increase in awareness about preventive care is expected to boost the growth of the global surgical face masks market.
    • However, supply shortage of face masks owing to increase in usage by the general public is anticipated to hamper the growth of the global market. Moreover, rise in prices of face masks is likely restrain the global surgical face masks market.
    • Surge in number of COVID-19 cases in developing and developed countries presents lucrative opportunity in the global surgical face marks market. According to WHO data, the total confirmed cases of COVID-19 recorded in major countries as of March 30, 2020 stood at 82,447 cases in China, 97,689 in Italy, 78,797 in Spain, 38,309 in Iran, and 122,653 in the U.S.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=42122

    North America to Capture Major Share of Global Surgical Face Masks Market

    • North America is projected to account for major share of the global surgical face masks market due to high prevalence of infectious diseases among the population. Moreover, rise in awareness and presence of key players are anticipated to drive the market in the region. Europe is expected to account for significant share of the global market. The market in the region is likely to expand at a moderate CAGR during the forecast period.
    • The surgical face masks market in Asia Pacific is projected to grow at a rapid pace during the forecast period owing to rise in awareness and increase in cases of infectious diseases

    Key Players Operating in Global Surgical Face Masks Market

    The global surgical face masks market is highly consolidated due to the presence of small number of key players. Demand for surgical face masks has increased in emerging as well as developed markets owing to rise in prevalence of infectious diseases such as COVID-19. Growth strategies adopted by leading players are likely to drive the global market. Industry players are adopting the practice of appointing third-party distributors to expand market presence. This has led to a surge in the number of distributors and suppliers in the emerging markets.

    More Trending Reports by Transparency Market Research –  

    Ileostomy Market -

    https://www.prnewswire.com/news-releases/ileostomy-market-to-reach-an-evaluation-of-us1-65-billion-by-2024--says-tmr-300809103.html

    Urinary Catheters Market –

    https://www.biospace.com/article/urinary-catheters-market-increasing-urinary-incontinence-to-accelerate-market-growth/


  • Medical Device Technologies Market to Observe Strong Development by 2025

    According to a recent report compiled by Transparency Market Research (TMR), the competitive landscape of the global medical device technologies market is estimated to show remarkable growth owing to the technological advancements in the health and medical sector. The technological advancements used in medical gadgets has ensured a notable development in terms of treating illness and diagnosing them.

    Some of the major players of the global medical device technologies market are Baxter International Inc., Boston Scientific Corporation, Johnson & Johnson, Medtronic plc, and Smith & Nephew plc. The market is mostly dominated by companies manufacturing in vitro diagnostic devices as they hold the maximum revenue share of the market. Nevertheless, small players are leaving no stone unturned in order to secure their place in the market worldwide.

    Planning To Lay Down Future Strategy? Request Brochure Of Medical Device Technologies Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11705

    As per the TMR report, the global medical device technologies market is anticipated to earn US$563.8 bn by the end of 2025. The market is estimated to expand with a CAGR of 4.6% within the forecast period of 2017 to 2025. Based on end user, academics and hospitals and research segment is seen to be leading the market share. From a geographical perspective, the market is seen to be dominated by North America followed by Europe.

    To Obtain All-Inclusive Information On Forecast Analysis Of Medical Device Technologies Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=11705

    North America to Dominate Market with Critical Therapeutic Treatment

    The market for medical device technologies is mainly dominated by the regions of North America, Middle East and Africa, Asia Pacific, Europe and Latin America. Among these, the market in North America is seen to be holding the lion’s share owing to the increase in the number of patients of both metabolic as well as chronic diseases like cancer, and cardiovascular diseases. These kind of diseases demand both critical therapeutic treatment and diagnosis along with extra care of the patient. The presence of numerous manufacturers in the region is also drawing more revenue generation of the North American region. Apart from that, automated medical processes demand is also expected to fuel the medical device technologies market in the years to come.

    Medical sector technologies have also brought out to be sustainable, productive as well as efficient in terms of healthcare facilities.  It is also accompanied by smart gadgets like ultrasound systems, and constant glucose monitoring system along with other medical devices. At present, many clinics and hospitals are focusing more on installation of automated processes and implementing them in order to lower the possibility of errors as it is concerned with the patient’s wellbeing. This is further adding to draw more revenue share into the overall market, hence boosting the market growth. Other factors anticipated to boost the demand for medical device technologies in the market are quick and steady data analysis along with workflow automation.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=11705

    Non-License Technology Affecting Market Growth in Negative Light

    Although the medical device technologies market is seeing rapid growth, factors like the increasing incidence of non-license technology for integrating biomedical devices may act as a hindrance to the overall growth of the market in the future years to come. However, the introduction of hi-tech devices bringing positive results have offered lucrative opportunities for the future growth of the market in the long run.

    More Trending Reports by Transparency Market Research –  

    Anti-Snoring Devices and Snoring Surgery Market -

    https://www.prnewswire.com/news-releases/anti-snoring-devices-and-snoring-surgery-market-to-touch-us22-7-billion-by-2024--says-tmr-300808446.html

    Synthetic Absorbable Sutures Market –

    https://www.biospace.com/article/synthetic-absorbable-sutures-market-biocompatibility-and-porosity-of-materials-become-key-focus-points-for-suture-innovations/


  • Orthopedic Devices Market to Expand with Significant CAGR by 2026

    Transparency Market Research finds, the competitive landscape of the global orthopedic devices market to be highly fragmented with a plethora of players. Some of the prominent players operating in the global orthopedic devices market are Stryker, DePuy Synthes, Smith & Nephew, Zimmer Biomet, Medtronic Spinal, DJO Global, and Arthrex, Inc.

    Key players in the market are adopting several strategies such as acquisitions and mergers, business expansion and collaboration to expand their geographical reach, says TMR. In September 2016, Stryker acquired Instratek, Inc.,  - a U.S.-based orthopedic implants and endoscopic instrument manufacturer. This acquisition helped Stryker fortify its market share in the orthopedic devices market.

    The orthopedic devices market is projected to attain a valuation of US$ 65,000 mn by 2026. The market is anticipated to rise at a steady CAGR of over 3.0% from 2018 to 2026. TMR analysts noted the market at a valuation of US$ 46,900 mn in 2017 

    Planning To Lay Down Future Strategy? Request Brochure Of Orthopedic Devices Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1781

    Based on product, the joint reconstruction segment dominates the global market owing to the rising demand of orthopedic devices among consumers. However the segment is expected to lose market share over spinal devices segment towards the end of the forecast period. This is because of stringent FDA regulations for product approvals and high investments. On the basis of geography, North America is projected to lead the market during the forecast period. Factors such as rising geriatric population, developed medical infrastructure and presence of key players are expected to drive the global orthopedic devices market in the region.

    To Obtain All-Inclusive Information On Forecast Analysis Of Orthopedic Devices Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1781

    Increasing Geriatric Population Base across Globe to Boost Market

    The global orthopedic devices market is projected to grow at a significant pace during the forecast period. This is mainly because of the growing geriatric population across the globe. Geriatric people are highly susceptible to develop bone related disorders.  This is expected to increase demand for various orthopedic implants and devices from this populaces. Apart from this, rising prevalence of diabetes and obesity, poor diet, lack of physical activity, and rising trend of smoking and alcohol consumption are some factors that can cause damage to bone health. This could pave way for the growth of sorthopedic devices market.

    Along with this, innovations in the field of osteology such as advancement in 3D printing, robot-assisted surgical procedures, and smart implants are helping manufacturers cut down cost of the orthopedic devices. This is leading to an increasing adoption of orthopedic devices in the emerging economy as well thus offering a significant push to the orthopedic devices market. 

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1781

    Inefficiency and Manufacturing Errors of Orthopedic Devices to Hamper Growth

    Despite several drivers, the growth in the orthopedic devices market is hampered due to the rising incidence of device failure and manufacturing errors. This is preventing widespread adoption of orthopedic devices among surgeons and patients, which in turn affects sales. The recalls and associated lawsuits have criticized orthopedic companies leading to loss of reliability in the minds of customers. For example, in December 2016, Greatbatch Medical, has launched faulty offset cup impactor device in the market. The device failed sterility test, following which product recall and associated lawsuit led to criticism for the company for its reckless behavior.

    However, surge in road accidents and sports injuries, and spurring demand for minimally invasive surgeries are key drivers likely to offer lucrative avenue for the growth of the global orthopedic devices market.

    More Trending Reports by Transparency Market Research –  

    Infusion Pumps Market –

    https://www.prnewswire.com/news-releases/infusion-pumps-market-to-attain-valuation-of-us-10-000-0-million-by-2026--favorable-government-policy-to-boost-market-growth-says-tmr-300791560.html

    Molecular Diagnostics Market –

    https://www.biospace.com/article/molecular-diagnostics-market-implementation-of-pcr-based-techniques-spur-revenues/


  • Antiseptic and Disinfectant Market Estimated to Record Highest CAGR by 2026

    The global antiseptic and disinfectant market was valued at US$ 6.3 Bn in 2017. It is projected to expand at a compound annual growth rate (CAGR) of 6.2% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled “Antiseptic and Disinfectant Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. The report suggests that rising awareness regarding home cleanliness and the need for disinfection and rising concern regarding healthcare-acquired infections is expected to boost the antiseptic and disinfectant market in the near future.

    North America and Europe are projected to dominate the global market owing to increase in demand for efficient and effective management of antiseptic and disinfectant and the high rate of adoption of antiseptic and disinfectant for treatment planning by doctors as well as patients. The market in Asia Pacific is projected to witness expansion at a significant growth rate during the forecast period. Expansion of the market in Asia Pacific is attributed to the large base of private clinics and hospitals, rising geriatric population requiring hospital services after surgery, and increasing adoption of antiseptics for wound care therapy. The market for antiseptic and disinfectant in Latin America is likely to expand at a moderate growth rate during the forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Antiseptic and Disinfectant Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1695

    Value Added Features in Antiseptic & Disinfectant to Fuel Global Market

    The global antiseptic and disinfectant market is projected to be potentially driven by the value added features offered by various antiseptic and disinfectant manufacturing companies in order to streamline the day-to-day work flow in treating the patients and increase the revenue of the practices. The antiseptic and disinfectant manufacturing companies provide a wide range of features and benefits from patient pain heeling remedies to treatment procedures, which can be utilized by physicians and hospital staff to treat patients. These features help physicians and nurses to streamline the wound care treatment activity required for patients in order to maintain their daily workflow efficiently and effectively.

    The key players offering the antiseptic and disinfectant are developing value added features such as effective surgical units with disinfectant sprayer, molecular modeling of proteins and enzymes, thereby reducing the overall chances of infection and thus, improving the overall effectiveness and efficiency of medical or surgery practices. Companies are focusing on the development of combined therapy facilities in their systems in order to effectively integrate the therapy or treatment procedure along with the formulation of antiseptics & drugs, and patient education & awareness programs. These value added features save the operational time of physicians and help improve the performance of the healthcare provider.

    To Obtain All-Inclusive Information On Forecast Analysis Of Antiseptic and Disinfectant Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1695

    Hydrogen Peroxide is projected to be Highly Lucrative Deployment Mode

    Traditionally, hydrogen peroxide-based antiseptics and disinfectants were commonly utilized in wound therapy and other disinfectant constituents. Hydrogen peroxide products possess a greater activity against gram-positive than gram-negative bacteria. Hydrogen peroxide is widely employed as a biocide for disinfection, sterilization, and antisepsis and is commercially available in a variety of concentrations, ranging from 3% to 90%.

    Furthermore, these hydrogen peroxide based antiseptics and disinfectants are priced on perpetual license model and are moderately priced. Hydrogen peroxide products enable the user to practice low frequency clinical applications, allow the healing of extreme pain due to infection, and assurance of 90% recovery features by physicians are likely to propel the segment during forecast period. These hydrogen peroxide-based products address specific challenges faced during the treatment procedure due to the presence of catalase or other peroxidases in the organisms, which can increase tolerance in the presence of lower concentrations of hydrogen peroxide. Hydrogen peroxide-based products facilitate results in antisepsis and increase the level of disinfection & sterilization strength along with a combination of other chemicals.

    Healthcare Providers Dominates the Market and the Commercial Users Segment is estimated to Expand at Second-highest CAGR During the Forecast Period

    In terms of end-user, the healthcare providers segment accounted for leading share of the global antiseptic and disinfectant market. It is estimated to gain market share by the end of 2026, expanding at a CAGR more than 6% during the forecast period. Expansion of the life sciences industry, hospitals, and pharmaceutical industry, etc. has led to the prominent share held by the healthcare providers segment in the global antiseptic and disinfectant market. Increasing number of multinational hospital chains and high digitization budgets for sterilization techniques are likely to drive the healthcare providers segment during the forecast period. High prevalence and incidence rates of hospital acquired infection, expansion of the hospitality and hotel industry, public hygiene, etc. are likely to boost the commercial users segment between 2018 and 2026.

    Asia Pacific Offers Potential Business Development Opportunity.

    North America and Europe accounted for a key share of the global antiseptic and disinfectant market in 2016. These are likely to gain market share by the end of 2026. High adoption of digital platforms for sterilization technique, and government initiatives to promote the minimally invasive surgery techniques have contributed to leading share of these regions in the global antiseptic and disinfectant market. Asia Pacific is projected to be a highly attractive market for antiseptic and disinfectant, and is likely to exhibit a considerably high attractiveness index. The market in Asia Pacific is projected to expand at high CAGR of more than 7% during the forecast period due to a large number of clinics in emerging countries such as India, China, well-established healthcare facilities, and high adoption of digital healthcare technology in countries such as Japan, Australia & New Zealand, Malaysia, and Singapore. The market in Latin America is anticipated to expand at a moderate growth rate during the forecast period.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1695

    Key Trend of R&D to Increase Geographic Presence Observed among Leading Players

    The report also provide profiles of leading players operating in the global antiseptic and disinfectant market. 3M Company, Novartis Ag, Johnson & Johnson, STERIS plc, Getinge Group, and Cardinal Health are some of the leading players operating in the global antiseptic and disinfectant market and account for a significant market share. Companies operating in the antiseptic and disinfectant industry are focusing on increasing their geographic presence by means of strategic acquisition and collaboration with leading players in respective domains and geography. According to Thornton & Ross, it has merged with Genus Pharmaceuticals, which is expected to increase the company's OTC brand business in the near future. Other prominent players operating in the global antiseptic and disinfectant include Becton, Dickinson And Company, Whiteley Corporation, and Kimberly-Clark.

    More Trending Reports by Transparency Market Research –

    Strides in Medical Tourism Market –

    https://www.prnewswire.com/news-releases/strides-in-medical-tourism-market-key-driver-of-low-cost-patient-care-in-globalized-healthcare-systems-notes-tmr-301058469.html

    Histone Deacetylase Inhibitors Market –

    https://www.biospace.com/article/histone-deacetylase-inhibitors-market-oncology-is-expected-to-be-a-major-segment-of-the-market-due-to-large-patient-population/


  • Antiseptic and Disinfectant Market Estimated to Record Highest CAGR by 2026

    The global antiseptic and disinfectant market was valued at US$ 6.3 Bn in 2017. It is projected to expand at a compound annual growth rate (CAGR) of 6.2% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled “Antiseptic and Disinfectant Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. The report suggests that rising awareness regarding home cleanliness and the need for disinfection and rising concern regarding healthcare-acquired infections is expected to boost the antiseptic and disinfectant market in the near future.

    North America and Europe are projected to dominate the global market owing to increase in demand for efficient and effective management of antiseptic and disinfectant and the high rate of adoption of antiseptic and disinfectant for treatment planning by doctors as well as patients. The market in Asia Pacific is projected to witness expansion at a significant growth rate during the forecast period. Expansion of the market in Asia Pacific is attributed to the large base of private clinics and hospitals, rising geriatric population requiring hospital services after surgery, and increasing adoption of antiseptics for wound care therapy. The market for antiseptic and disinfectant in Latin America is likely to expand at a moderate growth rate during the forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Antiseptic and Disinfectant Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1695

    Value Added Features in Antiseptic & Disinfectant to Fuel Global Market

    The global antiseptic and disinfectant market is projected to be potentially driven by the value added features offered by various antiseptic and disinfectant manufacturing companies in order to streamline the day-to-day work flow in treating the patients and increase the revenue of the practices. The antiseptic and disinfectant manufacturing companies provide a wide range of features and benefits from patient pain heeling remedies to treatment procedures, which can be utilized by physicians and hospital staff to treat patients. These features help physicians and nurses to streamline the wound care treatment activity required for patients in order to maintain their daily workflow efficiently and effectively.

    The key players offering the antiseptic and disinfectant are developing value added features such as effective surgical units with disinfectant sprayer, molecular modeling of proteins and enzymes, thereby reducing the overall chances of infection and thus, improving the overall effectiveness and efficiency of medical or surgery practices. Companies are focusing on the development of combined therapy facilities in their systems in order to effectively integrate the therapy or treatment procedure along with the formulation of antiseptics & drugs, and patient education & awareness programs. These value added features save the operational time of physicians and help improve the performance of the healthcare provider.

    To Obtain All-Inclusive Information On Forecast Analysis Of Antiseptic and Disinfectant Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1695

    Hydrogen Peroxide is projected to be Highly Lucrative Deployment Mode

    Traditionally, hydrogen peroxide-based antiseptics and disinfectants were commonly utilized in wound therapy and other disinfectant constituents. Hydrogen peroxide products possess a greater activity against gram-positive than gram-negative bacteria. Hydrogen peroxide is widely employed as a biocide for disinfection, sterilization, and antisepsis and is commercially available in a variety of concentrations, ranging from 3% to 90%.

    Furthermore, these hydrogen peroxide based antiseptics and disinfectants are priced on perpetual license model and are moderately priced. Hydrogen peroxide products enable the user to practice low frequency clinical applications, allow the healing of extreme pain due to infection, and assurance of 90% recovery features by physicians are likely to propel the segment during forecast period. These hydrogen peroxide-based products address specific challenges faced during the treatment procedure due to the presence of catalase or other peroxidases in the organisms, which can increase tolerance in the presence of lower concentrations of hydrogen peroxide. Hydrogen peroxide-based products facilitate results in antisepsis and increase the level of disinfection & sterilization strength along with a combination of other chemicals.

    Healthcare Providers Dominates the Market and the Commercial Users Segment is estimated to Expand at Second-highest CAGR During the Forecast Period

    In terms of end-user, the healthcare providers segment accounted for leading share of the global antiseptic and disinfectant market. It is estimated to gain market share by the end of 2026, expanding at a CAGR more than 6% during the forecast period. Expansion of the life sciences industry, hospitals, and pharmaceutical industry, etc. has led to the prominent share held by the healthcare providers segment in the global antiseptic and disinfectant market. Increasing number of multinational hospital chains and high digitization budgets for sterilization techniques are likely to drive the healthcare providers segment during the forecast period. High prevalence and incidence rates of hospital acquired infection, expansion of the hospitality and hotel industry, public hygiene, etc. are likely to boost the commercial users segment between 2018 and 2026.

    Asia Pacific Offers Potential Business Development Opportunity.

    North America and Europe accounted for a key share of the global antiseptic and disinfectant market in 2016. These are likely to gain market share by the end of 2026. High adoption of digital platforms for sterilization technique, and government initiatives to promote the minimally invasive surgery techniques have contributed to leading share of these regions in the global antiseptic and disinfectant market. Asia Pacific is projected to be a highly attractive market for antiseptic and disinfectant, and is likely to exhibit a considerably high attractiveness index. The market in Asia Pacific is projected to expand at high CAGR of more than 7% during the forecast period due to a large number of clinics in emerging countries such as India, China, well-established healthcare facilities, and high adoption of digital healthcare technology in countries such as Japan, Australia & New Zealand, Malaysia, and Singapore. The market in Latin America is anticipated to expand at a moderate growth rate during the forecast period.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1695

    Key Trend of R&D to Increase Geographic Presence Observed among Leading Players

    The report also provide profiles of leading players operating in the global antiseptic and disinfectant market. 3M Company, Novartis Ag, Johnson & Johnson, STERIS plc, Getinge Group, and Cardinal Health are some of the leading players operating in the global antiseptic and disinfectant market and account for a significant market share. Companies operating in the antiseptic and disinfectant industry are focusing on increasing their geographic presence by means of strategic acquisition and collaboration with leading players in respective domains and geography. According to Thornton & Ross, it has merged with Genus Pharmaceuticals, which is expected to increase the company's OTC brand business in the near future. Other prominent players operating in the global antiseptic and disinfectant include Becton, Dickinson And Company, Whiteley Corporation, and Kimberly-Clark.

    More Trending Reports by Transparency Market Research –

    Strides in Medical Tourism Market –

    https://www.prnewswire.com/news-releases/strides-in-medical-tourism-market-key-driver-of-low-cost-patient-care-in-globalized-healthcare-systems-notes-tmr-301058469.html

    Histone Deacetylase Inhibitors Market –

    https://www.biospace.com/article/histone-deacetylase-inhibitors-market-oncology-is-expected-to-be-a-major-segment-of-the-market-due-to-large-patient-population/


  • Rapid Infuser Device Market Key Manufacturers, Development Trends and Competitive Analysis

    Rapid infuser is a procedure/treatment which involves administration of rapid fluid used during surgical procedure. Rapid infuser device is able to deliver the fluid (human body fluid) from slow to rapid continuous flow. Rapid infuser device is prominently used in emergency situations for safe and effective treatment (when patients are admitted with hypovolemic shock or excessive blood loss). There are two prominent types of rapid infuser devices: one is driven by compressor, while the other is connected to hospital wall pressurized outlets.

    Report Overview @

    https://www.transparencymarketresearch.com/rapid-infuser-device-market.html

    Rapid infuser device is mostly used for the following surgical procedures:

    • Anesthesia and intensive care unit
    • Emergency unit
    • Obstetrics and gynecology
    • Urology division

    Planning To Lay Down Future Strategy? Request Brochure Of Rapid Infuser Device Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20582

    Convenient and most effective way of delivering fluids in short span of time are the major factors deriving the global market. Moreover, use of this device in anesthesia centers have evolved over the years owing to product enhancements and application of information and sensing technology. Manufacturers in this industry are achieving innovation in patient care through integration of enhanced patient monitors, innovative parameters, wireless devices, workflows, and integrated IT solutions. This has enabled clinicians and anesthesiologists to practice and deliver customized services to patients. Manufacturing companies are not only providing technically advanced products, but also value added services such as predictable patient care, access to clinical information, and thus, optimized reimbursement.

    Moreover, rise in incidence of chronic pulmonary diseases is accelerating market growth. According to new estimates by the World Health Organization, COPD is predicted to become the third leading cause of death by 2030. An estimated 64 million people were suffering from COPD in 2004. Moreover, approximately 13.6 million adults were diagnosed with COPD in the U.S. alone. A rise in geriatric population suffering from COPDs and asthma is further expected to accelerate the growth of the rapid infuser devices market. Increase in the number of surgeries demand development of rapid infuser devices. According to the Centers for Disease Control and Prevention (CDC), approximately 51.4 million surgical procedures were performed in the U.S. alone in 2010, which included 1.01 million cardiac catheterizations, 1.1 million endoscopic procedures of the small intestine (with or without biopsy), 499,000 endoscopic procedures of the large intestine (with or without biopsy), 395,000 coronary artery bypass grafts (CABG), 719,000 knee replacements, and 332,000 total hip replacements. It has also revealed that the number would increase in the near future. However, slow adoption rate of rapid infuser devices by hospitals is expected to hamper market growth.

    To Obtain All-Inclusive Information On Forecast Analysis Of Rapid Infuser Device Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=20582

    Geographically, the global rapid infuser devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America contributed to the largest share of market due to growing patient awareness, favorable initiative taken by the federal government and major market players are based in the region. Asia Pacific and Latin America is identified as the emerging region for rapid infuser devices. Manufacturers have taken advantage of the presence of relatively inexpensive skilled labor in these developing regions to set up manufacturing facilities and launch affordable innovative products. Moreover, the improving scenario for availing better health care facilities in countries such as India and China and the burgeoning medical tourism market in Asia is likely to offer immense growth opportunities in the rapid infuser devices market. Therefore, existing players are recommended to invest in emerging economies to increase their market shares.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=20582

    Key players operating in the global rapid infuser devices market include 410 Medical, Inc., Belmont Instrument Corporation, Smisson-Cartledge Biomedical, LLC, and ZOLL Medical Corporation.

    More Trending Reports by Transparency Market Research –

    Geriatric Medicines Market –

    https://www.prnewswire.co.uk/news-releases/rising-incidence-of-chronic-disorders-in-elderly-to-drive-demand-within-the-global-geriatric-medicines-market-tmr-891385678.html

    Optometry Market –

    https://www.biospace.com/article/optometry-market-contact-lenses-to-see-increased-uptake-due-to-their-ability-to-treat-refractive-errors/


  • Veterinary Biologics Market Key Insights, Profiling Companies and Growth Strategies

    Global Veterinary Biologics Market: Overview

    Immunity is a biological defense mechanism to avoid infection or disease. When the autoimmune system fails, biologic drugs play a vital role in defending against diseases or infections by boosting the immune system. Veterinary biologics are products derived from living organisms and biological processes. These are used to prevent, diagnose, or treat animal diseases and function through an immunological process.

    Report Overview @

    https://www.transparencymarketresearch.com/veterinary-biologics-market.html

    Global Veterinary Biologics Market: Key Trends

    Rise in prevalence of animal diseases, increase in disposable income, focus of major players in the research and development of new vet biologic products to combat new animal diseases are projected to drive demand for veterinary biologics products. Moreover, increase in investments by government bodies and rise in demand for milk, meat, eggs, and fish are the other factors anticipated to propel the global veterinary biologics market during the forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Veterinary Biologics Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=63312

    Global Veterinary Biologics Market: Segmentation

    The global veterinary biologics market can be segmented based on product, disease type, animal type, distribution channel, and region. In terms of product, the global market can be classified into vaccines, diagnostic kits, immunomodulators, antiserums & antibodies, and others. The vaccines segment can be categorized into inactivated vaccines, conjugate vaccines, live attenuated, and toxoid vaccines. The vaccines segment is projected to account for significant share of the market in the near future. This is because of technological advances in vaccine development, continuous development of drug resistance by pathogens, and emergence of new diseases.

    Moreover, veterinary vaccine development generally has less stringent regulatory and preclinical trial requirements. Therefore, new players have the opportunity to enter the market through new product development. Based on animal type, the global veterinary biologics market can be bifurcated into livestock animals and companion animals. Usage of veterinary biologics is higher in livestock animals. Hence, the livestock animals segment is anticipated to dominate the market. Livestock animals are more prone to new diseases. Hence, proper vaccination is required. In terms of disease type, the market can be divided into bluetongue, foot & mouth disease, brucellosis & tuberculosis, and others. Based on distribution channel, the global veterinary biologics market can be classified into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment dominated the market in 2017 due to favorable government support and availability of all types of vet treatment.

    To Obtain All-Inclusive Information On Forecast Analysis Of Veterinary Biologics Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=63312

    Global Veterinary Biologics Market: Regional Analysis

    In terms of region, the global veterinary biologics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. The region is projected to account for significant share of the global veterinary biologics market during the forecast period, owing to increase in concerns about pet health and high cost of products. Favorable government support for the development of new biologic drugs is anticipated to drive the market in Europe. In December 2015, the Biotechnology and Biological Sciences Research Council (BBSRC) funded GBP 5.7 Mn for the development of poultry vaccines to the London School of Hygiene and Tropical Medicine. A rising trend of zoonotics, mandatory government requirement for immunization of animals, and trend of keeping companion animals are the major factors that drive the veterinary biologics market in Asia Pacific.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=63312

    Global Veterinary Biologics Market: Competitive Landscape

    Major players operating in the global veterinary biologics market include Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Eli Lilly & Company, Abaxis, OMEGA, and Hebei Veyong Animal Pharmaceutical Co., Ltd.

    More Trending Reports by Transparency Market Research –

    Sterilization Services Market –

    https://www.prnewswire.com/news-releases/outbreak-of-covid-19-to-boost-the-growth-of-global-sterilization-services-market-during-the-tenure-of-2019-to-2027-tmr-301062487.html

    Hospital Pharmaceuticals Market –

    https://www.biospace.com/article/hospital-pharmaceuticals-market-demand-from-oncology-segment-to-surge-in-response-to-increasing-incidence-of-cancer/


  • Smart Pill Boxes & Bottles Market Will Escalate Rapidly in the Near Future

    Global Smart Pill Boxes & Bottles Market: Overview

    The smart pill boxes & bottles market is expected to register robust growth in the near future. The market home to a large number of new technological advancements, which are expected to cater to various demands of the healthcare sector. These include demands for efficiency, hygiene, robust packaging, and marketing solutions. This should not be surprising to many as technologies like 3D printing, new distribution channels like e-commerce, and automation in packaging are big trends on the horizon. Moreover, demand for personalised medicine, and growth of small retail clinics are also expected to bring big profit margins for players in the global smart pill boxes and bottles market.

    Planning To Lay Down Future Strategy? Request Brochure Of Smart Pill Boxes & Bottles Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73433

    Global Smart Pill Boxes & Bottles Market: Notable Developments

    Amazon Echo, Android Assistant, and Apple Siri are expected to make it easier for consumers to order online. This is in line with the growing e-commerce business model which is synchronizing consumer thoughts and feelings with automated actions. Unsurprisingly, Amazon’s new launch can overhear consumer conversation and order items for them. Additionally, big pharmacies like Walgreens have also announced delivery systems to cater to chronically ill patients. It is estimated that each year over 1,25,000 patients die due to chronic illnesses. The rising automation due to technology, the growing penetration of e-commerce, and the natural alternative to this system – the smart pills and boxes are likely to witness major growth in the near future.

    To Obtain All-Inclusive Information On Forecast Analysis Of Smart Pill Boxes & Bottles Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=73433

    Global Smart Pill Boxes & Bottles Market: Drivers and Restraints

    It is estimated that 70% adults do not adhere to physician’s advice on prescribed dosage among others. Moreover, due to the rising costs of hospitals, and rise of chronic illnesses, many patients opt for home care. Due to rising costs of insurance and large number of uninsured patients, and rising liabilities associated with negligence, this is expected to emerge as a major trend driving growth. Moreover, the non-adherence and subsequent costs can reach as high as $100 bn in a year. The rising demand for personalised medicine, the proven efficacy of the medicine, and growing demand for home care are likely to drive growth for the smart pill boxes and bottles market.

    Rising geriatric population worldwide is a major concern to the healthcare sector. This is likely to result in more home-stays for health services. Additionally, this is expected to drive demand for smart pills dispenser. For example, it is estimated that the aging population is likely to grow by over 60% in India and 71% in China. This is a major turnaround for players in the smart pill boxes and bottles market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73433

    Global Smart Pill Boxes & Bottles Market: Geographical Analysis

    The global smart pill boxes and bottles market is likely to witness robust growth in North America. The decision by big pharmacies like Walgreens to compete with online deliveries, the invent of 3D printing, and growing demand for personal medicine in the region are likely to drive this growth. Moreover, the rising demand for pills with easy dispension systems, and easy to open systems for the elderly are rising in demand. Moreover, the growing favouritism for small clinics wherein cosmetics and especially smart cosmetics are especially popular. This is expected to drive major growth for the smart pill boxes and bottles market in the near future.

    The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

    More Trending Reports by Transparency Market Research –

    Strides in Medical Tourism Market –

    https://www.prnewswire.com/news-releases/strides-in-medical-tourism-market-key-driver-of-low-cost-patient-care-in-globalized-healthcare-systems-notes-tmr-301058469.html

    Assistive Technologies for Visually Impaired Market –

    https://www.biospace.com/article/assistive-technologies-for-visually-impaired-market-north-america-to-remain-as-leading-segment/


  • Veterinary Ventilators Market : Value Chain, Stakeholder Analysis and Trends

    Veterinary ventilators are used in a wide variety of surgical conditions. Veterinary ventilation provides respiratory support for animals that are unable to maintain ventilation or oxygenation on their own. They play an important role in veterinary hospitals and clinics during surgical processes carried out among animals. Emergency veterinarians and intensive care unit technicians use veterinary ventilation units extensively for the support of lungs functioning in pets or animals.

    Report Overview @

    https://www.transparencymarketresearch.com/veterinary-ventilators-market.html

    Ventilation process is also required during three circumstances: persistent hypoventilation, severe hypoxemia (unresponsive to oxygen therapy), and excessive breathing or fatigue. New developments in veterinary ventilation devices enables comfortable humidified sleep therapy for animals, which is paving the way for more treatment options for animals.

    Planning To Lay Down Future Strategy? Request Brochure Of Veterinary Ventilators Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30521

    Major diseases such as respiratory muscle paralysis, snake envenomation, drug toxicities, coonhound paralysis, tick paralysis, myasthenia gravis, cervical disc disease, severe brain disease or head trauma, cardiac arrest, and lung disease are affecting the veterinary animals very frequently at a global level. Hence the high prevalence of respiratory disease among veterinary animals, rising veterinary animal disease awareness programs, growing research and development initiatives, growing demand for veterinary ventilators devices as it is easy-to-use and controls to make operations simple makes the devices most important driving factor for veterinary ventilators market.

    According to the University of Florida, Small Animal Hospital, 30% of dogs who are being ventilated for pneumonia are successfully taken off with the use of a ventilator and 75% of dogs ventilated due to respiratory muscle paralysis showed better prognosis with ventilators. Versatile devices such as compos X veterinary ventilator and comfortable humidified ventilators is projected to fuel the overall veterinary ventilators market. Varying cost of treatment using ventilators and growing sensitivity of ventilators toward animals is expected to hamper the growth of the veterinary ventilators market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Veterinary Ventilators Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=30521

    The veterinary ventilators market has been segmented by technology type, application type, end-users, and geography. In terms of technology type, the market is classified into electro-pneumatic, electronic, pneumatic, and mechanical. In terms of application, the market is classified into lungs disease, cervical disc disease, neuromuscular disease, and others. Lungs disease among animals is a fast growing application segment because of increasing hypoventilation among veterinary animals globally. According to an article published by the University of Georgia, animals ventilated due to hypoventilation carry the best prognosis with approximately 50% discharged, and 15% of animals ventilated for hypoxemia are discharged from the hospital. In terms of end users, the market is classified into veterinary diagnostic laboratories, life sciences and research & development, and veterinary hospitals.

    Geographically, the veterinary ventilators market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global veterinary ventilators market due to patient (veterinary animals) awareness with high per capita health care expenditure for veterinary units. Early-phase diagnosis and treatment of disease is driving the medical biotechnology market which in turn is expected to drive the veterinary ventilators market in North America.

    Europe is the second largest market for veterinary ventilators due to favorable government policies regarding veterinary farming and increasing demand for trading facilities for healthy veterinary animals. The veterinary ventilators market in Asia Pacific is expected to grow at a higher rate due to rising veterinary animal business & farms, and increasing per capita expenditure on veterinary sectors by governments. In addition, economic growth in the agriculture sector is supporting veterinary infrastructure improvement in developing countries such as India, Australia, and China. Thus, all the above mentioned factors collectively support the growth of the veterinary ventilators market which is estimated to increase the growth rate of the market segment in Asia Pacific region by 2025.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30521

    Major players operating in the global veterinary ventilators market include DRE Veterinary, Eickemeyer Veterinary Equipment Ltd., Equipement Veterinaire MINERVE, Metan Co., Ltd, Smiths Medical, DRE Veterinary (Avante Health Solutions), Miden Medical, Midmark Corp, JD Medical, Hallowell Engineering & Manufacturing Corporation, and Vetronic Services Ltd.

    More Trending Reports by Transparency Market Research –

    Cell Based Assays Market -

    https://www.prnewswire.com/news-releases/cell-based-assays-market-is-projected-to-collect-revenue-of-us19-710-7-million-by-2022--says-tmr-300810762.html

    Bowel Management Systems Market –

    https://www.biospace.com/article/bowel-management-systems-market-systems-segment-to-expand-at-prominent-growth-rate/


  • Downstream Processing Market Analysis and Opportunity Assessment up to 2026

    Global Downstream Processing Market: Overview

    The exceptional development of the biotechnology industry has pushed the growth of global downstream processing market to new heights. Downstream processing finds extensive use in the biotechnology sector to isolate and purify biological products. The isolation of biological products has helped the pharmaceutical industry to make strides.

    The global downstream processing market could be studied on the basis of technique, application, end user, product, and region.

    The report serves to provide a brilliant analysis of the global downstream processing market. It analyzes vital aspects with a strong focus on market dynamics, market segmentation, and competitive scenario in the downstream processing market.

    Planning To Lay Down Future Strategy? Request Brochure Of Downstream Processing Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58695

    Global Downstream Processing Market: Key Trends

    First and foremost, increasing demand for biosynthetic products for secondary application in pharmaceutics is the key factor driving the downstream processing market. At present, naturally sourced pharmaceuticals are increasingly witnessing demand due to their low risk of side-effects. Downstream processing enables recovery and purification of biosynthetic products from natural sources such as plant or animal tissue or fermentation broth. For example, downstream processing is a key step in the manufacture of antibiotics such as penicillin. The process involves purification and separation of antibiotics from a range of mediums.

    Downstream processing is applied in the commercial scale manufacture of monoclonal antibodies. Antibodies therapies generally involve long-term use of antibodies in substantial dose, because of which biopharmaceutical companies employ downstream processing for commercial scale production.

    To Obtain All-Inclusive Information On Forecast Analysis Of Downstream Processing Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=58695

    Furthermore, downstream processing is employed in the commercial production of biological products. Some of these biological products are vaccines for small pox and influenza. Downstream processing is used in the industrial production of enzymes. These enzymes find applications in food preservation and food processing that have commercial value.

    On the flip side, high cost of equipment for downstream processing and lack of trained personnel to conduct the process are limiting the growth of downstream processing market to some extent. In addition, purification bottleneck and lack of single-use options are some other factors challenging the downstream processing market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=58695

    Global Downstream Processing Market: Geographical Analysis

    The global downstream processing market could be spread across North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. As per the report findings, North America and Europe are established markets for downstream processing. These regions being long-established centers of scientific research make them key regions for downstream processing.

    However, Asia Pacific is likely to present new growth opportunities to players in the downstream processing market. Factors such as increasing demand for biopharmaceuticals and increasing R&D initiatives in the biopharmaceutical industry are indirectly spurring the downstream processing market in the region.

    Global Downstream Processing Market: Competitive Analysis

    The report mentions and profiles key players operating in the global downstream processing market. Thermo Fisher Scientific Inc., Danaher Corporation, Boehringer Ingelheim, Sartorius Stedium Biotech S.A Eppendorf AG, GE Healthcare, Merck Millipore, 3M Company, Lonza Group, and Finesse Solutions Inc. are some top companies in the downstream processing market identified in this report.

    More Trending Reports by Transparency Market Research –

    Invisible Orthodontics Market -

    https://www.prnewswire.com/news-releases/invisible-orthodontics-market-to-gain-us-7-259-6-million-by-2026--says-tmr-300809816.html

    Hemostatic Agents Market –

    https://www.biospace.com/article/hemostatic-agents-market-increasing-geriatric-population-to-enhance-growth-prospects-/


  • Optometry Market Key Trends and Opportunity Analysis up to 2025

    The global optometry market is envisioned in a report by Transparency Market Research (TMR) to hold a fragmented characteristic for its vendor landscape. Companies are observed to make desperate efforts to retain their shares of the market and grow strong in the coming years. With a view to outsmart their opponents, they are expected to rely on demand for improved treatments and therapies. With their extensive regional outreach and broad product portfolios, larger companies could take a leading position in the market. Some of the prominent companies functioning in the market are Pfizer, Inc., CooperVision, and Novartis AG.

    By 2025, the global optometry market could bag revenue worth a US$79.8 bn while expanding at a 4.1% CAGR during the forecast tenure 2017-2025 as foreseen by TMR. In 2016, it was valued at a US$55.9 bn. Anti-inflammatory drugs classified under therapeutics by type of product are envisaged to secure a higher share of the market, considering their 32.5% attained in 2016. By region, North America could collect a king’s share of the market, taking into account its 36.5% achieved in the same year.

    Planning To Lay Down Future Strategy? Request Brochure Of Optometry Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11810

    Vision Problems Propels Demand

    Diabetes and other chronic health conditions in geriatrics are researched to be among primary factors triggering vision problems in them. Moreover, geriatrics are observed to be highly vulnerable to vision complications due to other reasons. Thus, expansion of the geriatric population across the world is anticipated to serve as a powerful factor augmenting demand in the global optometry market. Demand for optometry could also increase on the back of swelling prevalence of cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD).

    In the U.S., diabetic retinopathy is observed to have affected nearly 7.6 mn people, as per the finding of the American Association of Ophthalmology. The organization also found another 20.5 mn people in the country affected by cataracts.

    To Obtain All-Inclusive Information On Forecast Analysis Of Optometry Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=11810

    Unaffordability in Emerging Countries Causes Demand to Grow Dull

    Low affordability and purchase power of developing economies could limit adoption of optometry therein. Patients may find it unaffordable to opt for optometry tests or purchase optometry drugs. However, government initiatives to make healthcare affordable for everyone are prognosticated to create opportunities in emerging regional markets. Growing awareness about eye care and need for eye tests due to rising incidence of refractive errors and eye diseases are foretold to set the international optometry market for positive growth in the near future.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=11810

    The possibility of finding cures for different visual problems on account of constant technological development could encourage players to expand their product portfolios. Furthermore, increasing preference for contact lenses and introduction of fashionable spectacles are projected to offer a wealth of opportunities in the market.

    More Trending Reports by Transparency Market Research –

    Anti-Snoring Devices and Snoring Surgery Market -

    https://www.prnewswire.com/news-releases/anti-snoring-devices-and-snoring-surgery-market-to-touch-us22-7-billion-by-2024--says-tmr-300808446.html

    Head and Neck Cancer Market –

    https://www.biospace.com/article/head-and-neck-cancer-market-asia-pacific-market-to-register-exponential-growth/


  • Body Sensor Market Growth Analysis up to 2022

    Need for smarter and smaller sensors will dominate the global body sensor market between 2017 and 2022. Thus, a number of wearable devices and an intense research and development environment would mark the forecast period, especially in the field of Internet of Things, Augmented Reality and Man-to-machine interactions.

    This is primarily due to rise in ageing population. As per World Health Organization Statistics, between 2015 and 2050, the population of people over 60 years will be up to 22% from 12%, nearly doubling over the period. Besides, an increase in fitness will also lead to growth in global body sensor market owing to a need to measure heart rate, pulse, oxygen levels etc. The ubiquity of smartphones facilitates the growth of body sensors market further. It is important to note here that not only can these sensors be used in smartphones but they can also be mounted on the body or planted inside it. Few can also be placed on clothes and bags.

    Planning To Lay Down Future Strategy? Request Brochure Of Body Sensor Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30104

    As per a Transparency Market Research report the market will grow at a stellar CAGR (Compound Annual Growth Rate). It is predicted to take up the worth of the market considerably.

    Increasing Market Adaptability with using Newer Technology

    Of the key product varieties in the market, the market has seen a significant rise in demand for temperature sensors. The segment is expected to accumulate a worth of US$23 mn in 2017, amounting to nearly 18.5% of the overall market in the said year. The market for temperature sensor is expected to rise to US$62 mn by 2022 while the CAGR will be 21.9% during 2017 to 2022. The contribution of temperature sensors segment is projected to acquire a 21.2% of the global market share by the end of the forecast period. It is also estimated to rise to US$7.8 mn annually. The most profitable regional market is North America, which is expected to expand at a 22.1% CAGR over the forecast period and is estimated to rise to US$100.9 mn by 2022.

    The segment is expected to remain profitable over the report’s forecast period as there will be high acceptability for newer technology across all consumer demographics, especially across geriatric population.

    To Obtain All-Inclusive Information On Forecast Analysis Of Body Sensor Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=30104

    A Technological Forte through AI, IOT and M2M

    The global body sensor market is witnessing a rapid change in its key consumer demographic as the demand for body sensors for use in applications associated with geriatrics has significantly increased over the years. The market is also driven due to the increased demand for products capable of providing real-time caring and monitoring, from customer-base with rising disposable incomes that is more focused on physical fitness and sports leagues. The rising use of body sensors for clinical trials and recent developments in the field of smart mobile user interface are also expected to drive the market.

    Body sensor are very high in demand as they have more relevance in today’s market where the users are cautious about body fitness, feasibility of using mobile phones, and increasing number of body sensors by sports professionals. As the devices are easily mounted and their accessibility and demand is increasing at a steady pace. The devices are smarter, smaller, and easily transportable, owing to which they find vast applications in the healthcare industry. The vast rise in research and development activities in areas of augmented reality, internet of things, and man-to-machine that are also favorable conditions for the global body sensor industry.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30104

    On the another hand, as rising use of connected devices that involve body sensors and the data accumulated through body sensors could create negative impact on individuals’ privacy, leading to regulatory issues, the uptake of a variety of devices could be hindered to a certain degree.. Nevertheless, despite the purview of these negative factors, there are still new prospects seen regarding the better use of body sensors, where opportunities can be met and obstacles can be curtailed.

    More Trending Reports by Transparency Market Research –

    Urinary Catheters Market -

    https://www.prnewswire.com/news-releases/urinary-catheters-market-to-hit-us5-0-billion-by-2025--says-tmr-300806623.html

    Animal Parasiticides Market –

    https://www.biospace.com/article/animal-parasiticides-market-ectoparasiticides-is-projected-to-be-highly-lucrative-deployment-mode/


  • CRISPR and Cas Genes Market Growth Prospects, Trends and Forecast up to 2026

    Transparency Market Research (TMR) has published a new report titled, “CRISPR and Cas Genes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global CRISPR and Cas genes market was valued at US$ 7,234.5 Mn by 2026, expanding at a CAGR of around 20.1% from 2018 to 2026. Increase in applications of CRISPR and Cas gene editing technology in bacteria and usage of gene editing technology for prevention of various diseases are the major factors anticipated to drive the market from 2018 to 2026. Rise in need of alternative medicine for chronic diseases and increase in investments by key players in Asia Pacific are projected to propel the market during the forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of CRISPR and Cas Genes Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26417

    Increase in Usage of DNA-free Cas

    DNA-free Cas9 is most commonly used with synthetic crRNA tracrRNA and chosen by researchers who strive to avoid unwanted vector DNA integration into their genomic DNA. CRISPR-Cas9 utilizing mRNA or protein is ideal for applications such as knocking of a fluorescent reporter using HDR or knockout cell line generation. Advantages such as gene editing with DNA-free CRISPR-Cas9 components to reduce potential off-targets and potential usage of CRISPR-Cas9 gene editing to find correlations with human diseases in model systems drive the segment.

    Rise in Incidence of Genetic Disorders and Increase in Applications of CRISPR and Cas Genes to Propel Market

    Genetic diseases are generally termed as rare diseases. According to NCBI, prevalence of these rare diseases is approximately 5 in 10,000. There are 6,000 to 8,000 rare diseases, with 250 to 280 new diseases diagnosed every year. Hence, 6% to 8% of the global population is projected to be affected by rare diseases i.e., genetic diseases in the near future. Researchers are developing treatments for these diseases with applications of new technologies such as CRISPR. The applications of CRISPR technology are expanding in other industrial sectors. This is expected to drive the market during the forecast period. Usage of CRISPR/Cas9 technology in plant research has enabled the investigation of plant biology in detail which has helped to create innovative applications in crop breeding. Site-directed mutagenesis and site-specific integration of a gene, which is also called knock-in, are important in precision crop breeding. Cas9/gRNA-mediated site-directed mutagenesis and knock-in is widely used in rice and Arabidopsis protoplasts. CRISPR/Cas9 provides a simple method to generate a DSB at a target site to trigger HDR repair.

    To Obtain All-Inclusive Information On Forecast Analysis Of CRISPR and Cas Genes Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=26417

    Ethical Issues Concerning Gene Editing Technology to Restrain Market

    Any changes in the human genome are made in the germline, and hence are expected to be passed on to the future generations. The safety and efficacy concerns with genome editing have gained momentum with the discovery of CRISPR, as it has the potential to make accurate use of genome editing technologies. Major ethical issues concerning the human genome editing technology are disturbance of the ecological equilibrium, patent regulations concerning CRISPR/Cas9 gene technology, non-therapeutic interventions using human genome, and formation of chimera which has the risk of violation of the order of nature and giving rise to moral confusion for treating organisms.

    Asia Pacific Market to Witness Exponential Growth

    In terms of revenue, the CRISPR and Cas genes market in Asia Pacific is expected to expand at a CAGR of 22.0% during the forecast period. Growth of the market in the region can be attributed to increase in incidence of chronic diseases such as cancer and the need of development of genetic engineered treatment options. According to the report, Call for Action: Expanding Cancer Care for Women in India, 2017, an estimated 0.7 million women in India are suffering from cancer. China dominated the CRISPR and Cas genes market in Asia Pacific. In 2016, scientists based in China launched the first known human trials of CRISPR, the genomic tech that involves slicing and dicing the body’s very source code to fight cancer. Japan was the second largest market for CRISPR and Cas genes in Asia Pacific.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=26417

    Addgene, Thermo Fisher Scientific, Inc., and Integrated DNA Technologies, Inc. to Lead Market

    The report also provides profiles of leading players operating in the global CRISPR and Cas market such as Synthego, Thermo Fisher Scientific, Inc., GenScript, Addgene, Merck KGaA (Sigma-Aldrich), Integrated DNA Technologies, Inc., Transposagen Biopharmaceuticals, Inc., OriGene Technologies, Inc., New England Biolabs, Dharmacon, Cellecta, Inc., Agilent Technologies, and Applied StemCell, Inc.

    More Trending Reports by Transparency Market Research –

    Wheelchairs Market -

    https://www.prnewswire.com/news-releases/wheelchairs-market-to-surpass-a-value-of-us-6-253-6-million-by-2026--says-tmr-300805704.html

    ECG Devices Market –

    https://www.biospace.com/article/ecg-devices-market-increase-in-incidence-of-cardiovascular-diseases-cvd-is-generating-demand-market/


  • Mechanical Ventilators Market Key Opportunities and Forecast up to 2027

    Transparency Market Research (TMR) has published a new report titled, ‘Mechanical Ventilators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global mechanical ventilators market was valued at US$ 1.9 Bn in 2018 and is projected to expand at a CAGR of above 12.8% from 2019 to 2027.

    Overview

    • Mechanical ventilation refers to artificial breathing devices that are utilized by patients that are unable to breathe naturally due to acute medical conditions.
    • Technological innovations in the last few decades have revolutionized the mechanical ventilators market, in terms of usage settings of these devices. Development in the technology and design of ventilators has expanded the use of mechanical ventilators not only in hospitals, but also in transport and home care settings.
    • North America dominated the global mechanical ventilators market in 2018 and the trend is anticipated to continue during the forecast period. Quick adoption of advanced product and strong government support in terms of investment is boosting the growth of mechanical ventilators market in North America.
    • However, Asia Pacific is likely to be a highly lucrative market for mechanical ventilators and it is expected to expand at a high CAGR during the forecast period

    Planning To Lay Down Future Strategy? Request Brochure Of Mechanical Ventilators Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1397

    Technological Advancement – Drives the Market

    • Critical care ventilators have undergone extensive evolution in their design, safety, and efficiency since their introduction. Integration of high-speed signal processing and on-board intelligent firmware in mechanical ventilation have resulted in offering certain clinical benefits such as faster weaning, better gas exchange and oxygenation, least damage to lungs, lesser side-effects, and minimal adverse effect on systemic and pulmonary circulation.
    • Ventilator manufacturers and assemblers in developing countries, such as India and China, have increased their efforts toward creating low-cost non-invasive ventilation solutions in order to cater to the local needs and bring flexibility in patient care.
    • Small local players are efficiently catering to the customization needs of their local markets through collaborations and partnerships, which the global companies do not find as a monetarily viable option.

    To Obtain All-Inclusive Information On Forecast Analysis Of Mechanical Ventilators Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1397

    Critical Care Ventilators Segment to Dominate Market

    • Based on product, the critical care ventilators segment accounted for the largest share of the mechanical ventilators market in 2018, rapid rise in the geriatric population, increase in incidence of chronic obstructive pulmonary disease and other respiratory emergencies, and technological innovation in respiratory care devices are major factors that are expected to drive the segment during the forecast period

    Non-invasive Ventilators Segment to Dominate Market

    • In terms of interface, noninvasive ventilators segment accounted for a dominant share of the market in 2018. Added portability in traditional invasive ventilators has paved the way for the introduction of non-invasive mechanical ventilators, and thereby, has fuelled the market.
    • The introduction of new portable and non-invasive ventilators has revolutionized the mechanical ventilators market; factors such as reduction in infection risk, patient’s ability to speak and swallow, and lesser need for sedation, drive the demand for non-invasive ventilators in the market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1397

    Hospitals and Clinics to be Highly Lucrative Segment

    • Based on end-users, the hospitals segment held the largest share of the market in 2018 due to increase in the number of critically ill patients as well as rising number of hospitals beds globally.
    • Furthermore, huge budgets of hospitals allow them to cater to the demands of patients for better quality outcomes.

    North America to Dominate Global Market

    • In terms of region, the global mechanical ventilators market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global mechanical ventilators market in 2018, followed by Europe.
    • North America accounted for major share of the global mechanical ventilators market in 2018, as the region has always been on the leading edge of medical device technology and adoption.
    • Key players are investing to expand their reach and strengthen their market position in North America market through new product development and approvals.

    Competitive Landscape

    • The global mechanical ventilators market is fragmented in terms of number of players. Key players in the global market include Teleflex Incorporated, VYAIRE, Dragerwerk AG & Co. KGaA, GE Healthcare, Medtronic plc, Koninklijke Philips N.V., Smiths Medical, ResMed Inc., Bunnell Inc., and Getinge AB. among others among others

    More Trending Reports by Transparency Market Research –

    Legionella Testing Market -

    https://www.globenewswire.com/news-release/2019/03/29/1788547/0/en/Legionella-Testing-Market-to-reach-a-value-of-US-398-7-million-by-2025-TMR.html

    Thrombosis Drugs Market –

    https://www.biospace.com/article/thrombosis-drugs-market-factor-xa-inhibitor-segment-dominated-the-market/


  • Smart Healthcare Products Market Opportunity Assessment and Forecast up to 2027

    Transparency Market Research (TMR) has published a new report titled, ‘Smart Healthcare Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global smart healthcare products market was valued at US$ 37.5 Bn in 2018 and is projected to expand at a CAGR of 8.8% from 2019 to 2027.

    Overview

    • Smart healthcare products enhance patient treatment and improve outcomes related to diagnostic tools along with improving their quality of life. These products come with embedded sensor technologies, communication, and data analytics techniques.
    • Smart healthcare products are usually used for physical monitoring of an individual for the diagnosis and ongoing disease treatment.
    • North America dominated the global smart healthcare products market in 2018 and the trend is anticipated to continue during the forecast period. Key factors attributing to its large share include favorable government initiatives, such as the implementation of the U.S. Health Information Technology for Economic and Clinical Health (HITECH) Act in 2009, which provided nearly US$ 64,000 to each healthcare practitioner who has adopted electronic health record systems.
    • Asia Pacific is likely to be a highly lucrative market for smart healthcare products and it is expected to expand at a high CAGR during the forecast period

    Planning To Lay Down Future Strategy? Request Brochure Of Smart Healthcare Products Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9437

    Smart healthcare products with IoT applications and Greater role of government in developing smart healthcare ecosystem to Drive Market

    • Advancements in sensors and the availability of IoT innovation are permitting medical equipment and healthcare hardware to gather, record and segment information that was not accessible in past.
    • Nowadays, smart healthcare gadgets are remote powered and can be utilized to monitor and gather patient data who are suffering from various medicinal syndromes.
    • Such critical data is also accessible to patients, and in addition medical groups can also gain access to it at any time and by using various platforms, such as smart phones or PCs.
    • Additionally, governments' significant and developing part as payer, controller, and market-shaper in the worldwide smart healthcare division cannot be downplayed.
    • In many nations, governing authorities are major the funder and supplier of medicinal services for its population; this is an exceptionally costly obligation, as population is increasing.
    • Globally, various governments are implementing expansive changes by cutting expenses and enhancing the nature of their medical services frameworks.
    • These factors are expected to drive the smart healthcare products during the forecast period.

    To Obtain All-Inclusive Information On Forecast Analysis Of Smart Healthcare Products Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=9437

    Smart Pill Segment to Grow at a Faster Rate during the Forecast Period

    • Based on product type, the global smart healthcare products market has been divided into smart syringe, smart pills, RFID smart cabinets, and electronic health record.
    • The smart pill segment is expected to grow at a faster rate during the forecast period.
    • Increased patient preference for minimally invasive surgeries is considered as a major factor that would serve as a gateway for the growth of smart pills segment during the forecast period.

    North America to Dominate Global Market

    • In terms of region, the global smart healthcare products market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global smart healthcare products market in 2018, followed by Europe.
    • North America accounted for major share of the global smart healthcare products market in 2018. Its dominance can be attributed to increase in prevalence and incidence of chronic diseases such as diabetes and cancer are becoming more common in Canada, and healthcare providers are investing more heavily in IT to account for the impending growth in demand for healthcare
    • The rise of the aging population is another reason to increase investments in healthcare IT, boosting the demand for smart healthcare products in North America
    • The smart healthcare products market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=9437

    Competitive Landscape

    • The global smart healthcare products market is fragmented in terms of number of players. Key players in the global market include Epic System Corporation, Allscripts Healthcare Solutions, Inc., eClinicalWorks, CapsoVision, Medtronic, Olympus Corporation, Becton Dickinson and Company, Terumo Corporation, Stanley Healthcare, TAGSYS, among others.

    More Trending Reports by Transparency Market Research –

    Dental 3D Printing Market -

    https://www.globenewswire.com/news-release/2019/03/28/1781467/0/en/Dental-3D-Printing-Market-will-be-worth-US-3-427-1-million-by-2025-TMR.html

    Bovine Respiratory Disease Treatment Market –

    https://www.biospace.com/article/bovine-respiratory-disease-treatment-market-pulmonary-care-and-preventive-measures-fuelling-advancement-in-treatment-procedures/


  • Metabolomics Market Size, Analysis and Forecast up to 2024

    Transparency Market Research in its new report predicts that the global metabolomics market will undergo a tremendous transformation in the near future. The research report graphs the development of the metabolomics market in recent years and gives in detail information about overall working dynamics of the same. The competition in the market has been intense in the last few years and has been constantly escalating as leading players in the market are trying to maintain their position. Such intense competition in the market can be credited to the large number of medium, small, and large-scale enterprises that are functioning in the market.

    Each of these market players are trying to bolster their product portfolio by adopting aggressive marketing strategies. Strategies such as mergers and acquisitions are becoming increasingly common. Moreover, expansion of their production and manufacturing facilities has also been a key characteristic of the development strategies of the leading players in the metabolomics market. Some of the leading companies in the market are Thermo Fisher Inc., Human Metabolome Technologies, LECO, Shimadzu, Agilent Technologies, and Biocrates Life Sciences among others.

    Planning To Lay Down Future Strategy? Request Brochure Of Metabolomics Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=903

    According to the research report, the global metabolomics market is projected to exhibit a massive CAGR of 17.10% for the given forecast period of 2016 to 2024. In addition to this, the market is expected to achieve a stellar valuation of US$2.49 bn by the fall of 2024.

    To Obtain All-Inclusive Information On Forecast Analysis Of Metabolomics Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=903

    Developments in Pharma Sector to Push Market Growth

    The drug discovery sector and other associated sectors in the pharmaceutical domain have been identified as the chief contributors for the overall development of the global metabolomics market. In recent years, the customized medicines or personalized therapeutics have had massive breakthroughs due to the developments in the fields of life sciences, chemicals, and pharmaceuticals. This too has helped in the growth of the global metabolomics market. Rising activities of research and development and increasing funding or investments for the same have too played a crucial role in developing the metabolomics market in recent years. In addition to this, the governments across the globe have been supportive for such market developments and have offered lucrative business opportunities and subsidized facilities for further development. All these factors have thus contributed for the overall growth of the global metabolomics market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=903

    Lack of Awareness among End-users to Restrict Market Development

    There are however, some factors that might hamper the growth of the global metabolomics market and stop it from reaching its full potential. One of the major restraining factors for the market growth has been the serious lack of awareness among the end-users about the benefits of metabolomics. Moreover, there has been a mixed response of the people towards using such technologies. This too has acted as a restraining factor for the market growth.

    More Trending Reports by Transparency Market Research –

    Sterilization Services Market –

    https://www.prnewswire.com/news-releases/outbreak-of-covid-19-to-boost-the-growth-of-global-sterilization-services-market-during-the-tenure-of-2019-to-2027-tmr-301062487.html

    Specialty Enzymes Market –

    https://www.biospace.com/article/specialty-enzymes-market-growth-in-the-field-of-molecular-testing-to-drive-demand-/


  • Nonalcoholic Steatohepatitis Therapeutics Market Shares, Strategies and Opportunities 2025

    Transparency Market Research (TMR) in its latest research report on the global nonalcoholic steatohepatitis therapeutics market has observed that players within this market both new entrants as well as those established are making equal efforts to develop an enhanced and effective treatment for NASH disease. Key players operating in the market include: Gilead Sciences, Inc., Zydus Cadila, GENFIT SA, Conatus Pharmaceuticals, Intercept Pharmaceuticals Inc., Astazeneca Plc., Immuron Ltd., Galmed Pharmaceuticals Ltd., and Tobira Therapeutics, Inc. Most of the leading biopharmaceutical companies are striving to develop novel therapeutics for NASH treatment and are carrying out clinical trials. Many of the companies are based in the U.S. and are collaborating with academic institutes and research centres so as to conduct clinical trials.

    According to Transparency Market Research (TMR), the global nonalcoholic steatohepatitis therapeutics market will cross US$20.27 bn by 2025. By drug type, the demand for elafibranor is highest on account of its effectiveness in reducing the effects of the NASH disease as well as the fact that it is the most advanced drug available as of now. The second most popular drug type is obeticholic acid (OCA).

    Planning To Lay Down Future Strategy? Request Brochure Of Nonalcoholic Steatohepatitis Therapeutics Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7691

    North America and Europe Remain Most Attractive Regional Markets for NASH Therapeutics

    By geography, the nonalcoholic steatohepatitis therapeutics market is highly attractive in regions such as North America and Europe, as these two regions are majorly affected by NASH. The growth of this market is also associated with an increasing number of people in the region suffering from obesity and diabetes. The increasing incidences of high cholesterol as well as change in lifestyle are some of the other reasons behind the continued growth of the nonalcoholic steatohepatitis therapeutics market in these regions. High growth areas for nonalcoholic steatohepatitis therapeutics market in Europe include Germany, the U.K., Spain, Italy, and France.

    To Obtain All-Inclusive Information On Forecast Analysis Of Nonalcoholic Steatohepatitis Therapeutics Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=7691

    Appalling Cases of Obesity among a Vast Pool of Population Worldwide Continues to Fuel Demand for Effective NASH Therapeutics

    The growing incidences of NASH and nonalcoholic fatty liver diseases (NAFLD) among people worldwide is behind the rise in the demand for nonalcoholic steatohepatitis therapeutics. This demand is particularly high in the developed nations of North America and Europe. Research centres are putting in much efforts for finding an effective treatment for nonalcoholic steatohepatitis disease. The growing prevalence of obesity worldwide, including obese children have created a heightened concern and need for curing the NASH disease at an early stage and keep a check on the weight. Levels of cholesterol is also high among a vast pool of population today, especially in America and this will continue to fuel the growth of the nonalcoholic steatohepatitis therapeutics market. While no exact cure exists in the market today, the treatment for NAFLD and NASH is constantly being worked upon.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=7691

    As of now, there are no therapies which have been approved and thus, there is high dependency on off label agents which offer sub-optimal efficacy and safety. There are many drugs in the later stages of the pipeline and this is expected to drive the growth prospects of the market.

    More Trending Reports by Transparency Market Research –

    Strides in Medical Tourism Market –

    https://www.prnewswire.com/news-releases/strides-in-medical-tourism-market-key-driver-of-low-cost-patient-care-in-globalized-healthcare-systems-notes-tmr-301058469.html

    Anti-Obesity Prescription Drugs Market –

    https://www.biospace.com/article/anti-obesity-prescription-drugs-market-emergence-of-novel-innovations-to-offer-rich-growth-opportunity/


  • Blood Gas and Electrolyte Analyzer Market Size will Observe Lucrative Surge by the End 2023

    A recent report by Transparency Market Research states that global blood gas and electrolyte market is projected to witness a substantial growth in the tenure of 2017 to 2023. This growth of the market is attributed to the developing and improving healthcare infrastructure across the globe. This growth of the global blood gas and electrolyte market is attributed to the growing developments in healthcare sector. These developments are resulting in implementation of technologies that can help the care providers and patients in treating the diseases. For instance, hospitals are implementing technologies like AR and VR that can provide real-time simulation of human body that can help them understand the anomaly of the patient. Due to these growing developments, the global blood gas and electrolyte market shall witness a considerable growth in the projected tenure.

    Planning To Lay Down Future Strategy? Request Brochure Of Blood Gas and Electrolyte Analyzer Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1780

    The Market to Witness a 8.6% CAGR During the Tenure

    Based on the lucrative opportunities that the players of global blood gas and electrolyte market can leverage, the market shall witness a substantial 8.6% CAGR during the projected tenure. This is also means that the global blood gas and electrolyte market has ample of opportunities that can help the players to grow exponentially between 2017 and 2023. With this growth rate the global blood gas and electrolyte market is projected to reach to the value of US$ 3.48 bn by the end of 2023. This allows the market players to grow rapidly during the duration. The experts also suggests that the global blood gas and electrolyte market stood strong at the value of US$ 2.11 bn during 2016.

    To Obtain All-Inclusive Information On Forecast Analysis Of Blood Gas and Electrolyte Analyzer Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1780

    Benefits Such as Mobility Drives the Growth

    As the developments advances in healthcare sector. The mobility is one of the facility that every healthcare apparatus must have these days. This allow the devices to be effective while they are on the move. With technological developments the blood gas and electrolyte device can now have mobility. This allow the device to be used in certain emergency. With these technological developments, the blood gas and electrolyte devices are in much demand. Due to this demand the global blood gas and electrolyte market is growing rapidly from 2017 to 2023.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1780

    North America Emerges as Dominant Region

    North America dominated the global blood gas and electrolyte market in previous duration i.e 2016. The region accounted for US$ 683 mn during this period. The region is projected to continue its domination in the present forecast period. The dominance of North America is the result of the growing healthcare infrastructure in U.S. and Canada. Additionally, the presence of technology pioneers developing innovative solutions for healthcare sector is also a major factor that supports the domination of North America in global blood gas and electrolyte market from 2017 to 2023.

    More Trending Reports by Transparency Market Research –

    Surgical Retractors Market –

    https://www.prnewswire.com/news-releases/increasing-geriatric-population-set-to-underscore-growth-in-global-surgical-retractors-market-from-2020-to-2030-tmr-301081728.html

    Pulmonary Arterial Hypertension (PAH) Market –

    https://www.biospace.com/article/pulmonary-arterial-hypertension-pah-market-approval-of-new-drugs-to-expand-market-growth/


  • Micro Guide Catheters Market Demand, Insights and Forecast up to 2024

    Growing at an impressive CAGR (Compound Annual Growth Rate) of 7.6%, the global micro guide catheters market is set to accrue a hefty market worth between 2017 and 2024. As per a Transparency Market Research study, one of the leading causes of this growth is the preference for minimally invasive medical procedures and population of geriatrics seeing an upward curve.

    Besides, the more integrated, and efficient a medical system, the higher the probability of minimally invasive surgeries over traditional variant. The reason is that procedures take less time and patients can be discharged the same day.

    The global micro guide catheters market landscape is fragmented one and major players include Boston Scientific Corporation, Cardinal Health, Cook Medical, LuMend Corporation, Micro Therapeutics Inc., Philips N.V. and Volcano Corporation among others.

    Planning To Lay Down Future Strategy? Request Brochure Of Micro Guide Catheters Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11966

    Sedentary Lifestyle Contributing Positively to the Micro Guide Catheters Market

    It is pertinent to note here that as sedentary lifestyle marks a new normal for whole generations present and the ones to come, associated diseases like those of the heart see a steep rise. Since, complications post-surgery are minimized with the use of micro guide catheters, the market would be propelled on a high growth curve.

    To Obtain All-Inclusive Information On Forecast Analysis Of Micro Guide Catheters Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=11966

    Rising Geriatric Population boosting growth in the Global Micro Guide Catheters Market

    The geriatric population is growing at a very fast pace and as per a study conducted recently, it has been noted that one in six people in the world will be aged 65 and above by the year by the year 2050. As per World Health Organization, most people today will reach their 60s and probably beyond. By 2050, about 2 million people will be 60 and over which is a steep rise from the number of people in the age group in 2015 – 900 million. Currently, 125 million people are occupying the age group of 80 and above.

    This is an important consumer base for the micro-guide catheters market owing to the sheer number and problems associated with age, pushing the micro guide catheters market towards further growth. Coupling it up with a sedentary lifestyle and a poor diet are propelling the market on a higher curve.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=11966

    North America to Dominate the Market Landscape over the Forecast Period

    Owing to high healthcare expenditure and a rapidly increasing geriatric population, the North American region will account for a large share of global micro guide catheters market. By 2050, one in every four people in the region will fall in the age group of 65 and above.

    More Trending Reports by Transparency Market Research –

    Drug Discovery Outsourcing Market –

    https://www.prnewswire.com/news-releases/drug-discovery-outsourcing-market-to-clock-cagr-of-10--during-2020---2030-penetration-of-contract-research-organizations-keep-asia-pacific-highly-lucrative-market-notes-tmr-301077557.html

    Glioblastoma Multiforme Treatment (GBM) Market –

    https://www.biospace.com/article/glioblastoma-multiforme-treatment-gbm-market-rise-in-awareness-regarding-cancer-and-novel-therapies-to-boost-the-market/


  • Digital Pathology Market Size to Expand Significantly by the End of 2027

    Transparency Market Research (TMR) has published a new report titled, ‘Digital Pathology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global digital pathology market was valued at US$ 0.38 Bn in 2018 and is projected to expand at a CAGR of over 12.0% from 2019 to 2027.

    Overview

    • Digital pathology (DP) is an image-based platform that involves managing, analyzing and interpreting digital information reflected on a digitized slide. Digital pathology technologies are utilized in many application areas such as forensic pathology, oral pathology and human pathology. Digital pathology is poised to streamline the workflow and activities of diagnostic laboratories and pathologists in near future
    • Digital pathology market is currently booming owing to rise in research and development activities. Surge in incidence and prevalence of chronic diseases and demand for advanced therapeutics are leading to increase in demand for new drugs and medicines. This in turn is increase in focus of research and development.

    Planning To Lay Down Future Strategy? Request Brochure Of Digital Pathology Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1540

    • Increase in number of trade fairs and exhibitions are creating awareness about the benefits of digital pathology solution. For instance, the 2nd international conference of digital pathology was held in November 2017 which brought together research scientist, pathologist and professors from different countries to discuss the complete digital solution for pathology. Thus, rise in awareness towards usage of digital pathology solutions for diagnosis of disorders and diseases is anticipated to drive the growth of market.
    • North America dominate the global digital pathology market in 2018 and the trend is anticipated to continue during the forecast period. Well established healthcare infrastructure, early adoption of advanced solutions and vast patient pool are the factors anticipated to drive the global digital pathology market in the region.
    • Asia Pacific is likely to be a highly lucrative region for the digital pathology market and is expected to expand at a high CAGR during the forecast period. Demand for newer solutions, surge in geriatric population with various chronic diseases and growing government initiatives to improve healthcare infrastructure are key factors likely to boost the digital pathology market in Asia Pacific.

    To Obtain All-Inclusive Information On Forecast Analysis Of Digital Pathology Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1540

    Rising Adoption of Telepathology and Virtual Pathology to Drive Global Digital Pathology Market

    • IT and operations segments have rapidly expanded the use of virtualization technologies in the last few years. Pathology is considered to be visual science and telepatholgy and virtual pathology are the new landscape of diagnostic pathology
    • Recent advances in telecommunication, microelectronics, sensor manufacturing, and data analysis techniques have created new possibilities for telepatholgy and virtual pathology in digital pathology market
    • Telepatholgy is being practiced by many laboratories across the world and gaining popularity across the emerging economies which is expected to boost the growth of digital pathology market during the forecast period

    Image Analysis Software Segment to Dominate Digital Pathology Market

    • In terms of products, the global digital pathology market has been segmented into image analysis software and scanners. The image analysis software segment dominated the global digital pathology market in 2018 and the trend is projected to continue during the forecast period. Rising awareness about healthcare IT and rising demand for integrated advanced technology products are the factors anticipated to drive the growth of segment

    Diagnostic Laboratories Segment Hold a Major Share of Global Digital Pathology Market

    • In terms of end-user, the global digital pathology market has been classified into diagnostic laboratories, academic & research centers, pharmaceutical companies and others
    • The diagnostic laboratories segment is likely to dominate the digital pathology market during the forecast period. Increasing number of diagnostics laboratories while scarcity of skilled pathologist across the globe is anticipated to fuel the growth of segment.

    Diagnosis Segment to Dominate Global Digital Pathology Market

    • Based on application, the global digital pathology market has been segmented into diagnosis, consulting services, educational and others
    • The diagnosis segment dominated the global digital pathology market in 2018 and trend is projected to continue during the forecast period. Rising awareness about early diagnosis and increase in patient pool are the factors anticipated to drive the growth of segment.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1540

    North America to Dominate Global Digital Pathology Market

    • In terms of region, the global digital pathology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global digital pathology market in 2018, followed by Europe.
    • North America accounted for major share of the global digital pathology market in 2018. High disease prevalence, presence of key players and supportive healthcare infrastructure are the major drivers of the digital pathology market in the region.
    • The digital pathology market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. Rising awareness about telepathology, rise in healthcare infrastructure, unmet medical needs and untapped nature of the market are the key factors for market growth in the region

    Competitive Landscape

    • The global digital pathology market is fragmented in terms of number of players. Key players in the global digital pathology market include Leica Biosystems Imaging, Inc., OLYMPUS CORPORATION, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc. Koninklijke Philips N.V., Sectra AB and Inspirata

    More Trending Reports by Transparency Market Research –

    Video Telemedicine Market –

    https://www.prnewswire.com/news-releases/hipaa-complaint-video-consultations-gain-patient-acceptance-video-telemedicine-market-to-garner-cagr-of-13-during-2020--2030-finds-tmr-301072555.html

    Clostridium Vaccine (Animal Health) Market –

    https://www.biospace.com/article/clostridium-vaccine-animal-health-market-large-demand-of-pork-to-boost-the-growth-of-swine-segment/


connect